Veterinary Pharmacovigilance Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Veterinary Pharmacovigilance Market size is set to record a 12.7% CAGR during 2024-2032 driven by tightening regulatory requirements and an intensified emphasis on animal safety.

As awareness grows regarding adverse drug reactions and the importance of post-marketing surveillance in veterinary medicine, regulatory bodies are tightening guidelines to uphold the safety and efficacy of veterinary drugs. This regulatory momentum is urging pharmaceutical companies and veterinary practices to adopt robust pharmacovigilance systems for monitoring and reporting adverse events.

With the expansion of the diversity and intricacy of veterinary drugs and biologics, effective pharmacovigilance becomes paramount in risk management and ensuring animal welfare. The rise of cutting-edge technologies, like electronic health records and automated reporting systems, bolsters the efficient gathering and analysis of safety data. For example, in July 2023, AB Cube's SafetyEasy(R) Suite achieved ICH E2B compliance for electronic transmission of individual case safety reports after successful testing in China.

The industry is classified into solution, animal type, type, end-user, and region.

Based on type, the veterinary pharmacovigilance market size from the outsourced segment is expected to generate notable revenue by 2032. This is attributed to its provision of specialized expertise and cost-efficient solutions. By delegating pharmacovigilance tasks to specialized third-party providers, veterinary pharmaceutical firms and research entities can harness the advanced technologies and expertise of these firms to ensure thorough monitoring and reporting of adverse events.

In terms of end user, the veterinary pharmacovigilance market value from the veterinary hospitals segment is projected to observe a robust CAGR during 2024 - 2032. This is owing to their critical role in the administration and monitoring of veterinary drugs. As primary centers for animal care, veterinary hospitals are at the forefront of identifying and reporting adverse drug reactions and safety issues.

Asia Pacific veterinary pharmacovigilance industry size will grow substantially between 2024 and 2032. Rapid urbanization and rising disposable incomes have led to higher pet ownership and demand for advanced veterinary care, necessitating effective pharmacovigilance systems to ensure drug safety and efficacy in the region.

Product Code: 10276

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of zoonotic disease
  - 3.2.1.2 Increasing pet ownership
  - 3.2.1.3 Technological advancement in adverse drug reaction (ADR) reporting systems
  - 3.2.1.4 Growing awareness of animal health
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Data security and privacy concerns
  - 3.2.2.2 Limited awareness and education
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Solution, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
5.3 Services
- 5.3.1 Core services
  - 5.3.1.1 Signal detection
  - 5.3.1.2 ICSR case processing
  - 5.3.1.3 Risk management
  - 5.3.1.4 Aggregate reporting
  - 5.3.1.5 Other core services
- 5.3.2 Consulting services
  - 5.3.2.1 Safety database implementation
  - 5.3.2.2 PV strategy and operating model
  - 5.3.2.3 Audit risk analysis
  - 5.3.2.4 Other consulting services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Companion animals
6.3 Livestock animals
6.4 Other animal types

Chapter 7 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 In-house
7.3 Outsourced

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Veterinary hospitals
8.3 Veterinary companies
8.4 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 The Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Accenture
10.2 ArisGlobal
10.3 Azierta Contract Science Support Consulting
10.4 Biologit
10.5 Covetrus, Inc.
10.6 Ennov
10.7 Indivitrus
10.8 Knoell
10.9 Leon Research
10.10 Medfiles
10.11 PQE Group
10.12 Sarjen Systems Pvt. Ltd
10.13 Teknofarma
10.14 TekroLab